Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bioxcel Therapeutics Inc (BTAI)

56.34   -0.64 (-1.12%) 02-25 12:24
Open: 57.46 Pre. Close: 56.98
High: 60.36 Low: 56.1
Volume: 182,619 Market Cap: 1,373M
BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of dexmedetomidine for acute treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immuno-oncology agent for the treatment of prostate and pancreatic cancers, and other solid tumors. BioXcel Therapeutics, Inc. has a collaboration with Merck KGaA; Nektar Therapeutics, Inc.; and Pfizer Inc. to develop a therapy for treating pancreatic cancer. The company was founded in 2017 and is headquartered in New Haven, Connecticut. BioXcel Therapeutics, Inc. is a subsidiary of BioXcel Corporation.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 58.236 - 58.439 58.439 - 58.624
Low: 52.998 - 53.245 53.245 - 53.471
Close: 56.57 - 56.931 56.931 - 57.261

Technical analysis

as of: 2021-02-25 11:43:01 AM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 79.12     One year: 92.41
Support: Support1: 53.75    Support2: 45.10
Resistance: Resistance1: 67.74    Resistance2: 79.12
Pivot: 57.62
Moving Average: MA(5): 55.79     MA(20): 55.73
MA(100): 50.46     MA(250): 44.74
MACD: MACD(12,26): 1.34     Signal(9): 1.68
Stochastic oscillator: %K(14,3): 37.50     %D(3): 36.59
RSI: RSI(14): 55.43
52-week: High: 71.50  Low: 13.77  Change(%): 53.2
Average Vol(K): 3-Month: 53268  10-Days: 45731

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
BTAI has closed above bottom band by 48.5%. Bollinger Bands are 6.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 25 Feb 2021
BioXcel Therapeutics Starts Testing BXCL501 In Mid-Stage Delirium-Related Agitation Study - Benzinga

Wed, 24 Feb 2021
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) to Post FY2025 Earnings of $14.59 Per Share, Truist Securiti Forecasts - MarketBeat

Wed, 17 Feb 2021
BTAI: BXCL701 Shows Encouraging Anti-Tumor Activity When Combined with Pembrolizumab in mCRPC… - Yahoo Finance

Tue, 16 Feb 2021
Here's Why We're Not Too Worried About BioXcel Therapeutics' (NASDAQ:BTAI) Cash Burn Situation - Yahoo Finance

Tue, 09 Feb 2021
BioXcel Therapeutics - Consensus Indicates Potential 93.9% Upside - DirectorsTalk Interviews

Thu, 04 Feb 2021
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Expected to Post Earnings of -$0.87 Per Share - MarketBeat

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 24
Shares Float (M) 15
% Held by Insiders 39.80
% Held by Institutions 53.92
Shares Short (K) 3,670
Shares Short P. Month (K) 3,190

Stock Financials

EPS -3.450
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 9.070
Profit Margin
Operating Margin
Return on Assets (ttm) -30.3
Return on Equity (ttm) -54.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.806
Qtrly Earnings Growth
Operating Cash Flow (M) -54
Levered Free Cash Flow (M) -28

Stock Valuations

PE Ratio -16.65
PEG Ratio
Price to Book value 6.33
Price to Sales
Price to Cash Flow -25.84

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.